Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Endocrinology|November 30, 2006
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategiesDermot O'Toole, Alexandru Saveanu, Anne Couvelard, et al.
Drug Discovery Today|November 1, 2013
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapiesFederica Barbieri, Manuela Albertelli, Federica Grillo, et al.
Endocrine-Related Cancer|September 7, 2017
Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial formsCarole Guerin, Pauline Romanet, David Taieb, et al.
Frontiers in Endocrinology|May 13, 2025
Case Report: Late diagnosis of McCune-Albright with severe kyphoscoliosis, acromegaly and tertiary hyperparathyroidismAnna Bogusławska, Maria Komisarz-Calik, Alicja Hubalewska-Dydejczyk, et al.
Journal of Cancer Research and Therapeutics|October 21, 2009
RET genetic screening in patients with medullary thyroid cancer: the Moroccan experienceAinahi Abdelhakim, Anne Barlier, Mohamed Kebbou, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2013
Targeting dopamine receptors subtype 2 (D2DR) in pheochromocytomas: head-to-head comparison between in vitro and in vivo findingsAlexandru Saveanu, Frederic Sebag, Benjamin Guillet, et al.
World Journal of Surgery|January 9, 2010
Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?Anita Skandarajah, Anne Barlier, Nathalie Morlet-Barlat, et al.
Elife|November 28, 2024
Modeling corticotroph deficiency with pituitary organoids supports the functional role of <i>NFKB2</i> in human pituitary differentiationThi Thom Mac, Teddy Fauquier, Nicolas Jullien, et al.
Expert Review of Endocrinology & Metabolism|February 16, 2019
Congenital pituitary hormone deficiencies: role of LHX3/LHX4 genesFrederic Castinetti, Rachel Reynaud, Alexandru Saveanu, et al.
Annales D'Endocrinologie|December 16, 2017
Unilateral aggressive pheochromocytoma revealed by a massive intraperitoneal hemorrhage five years after an initial presentation suggesting an adrenal hematomaOlivier Gilly, Françoise Brucker-Davis, Jean-Louis Bernard, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Endocrinology|November 30, 2006
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategiesDermot O'Toole, Alexandru Saveanu, Anne Couvelard, et al.
Drug Discovery Today|November 1, 2013
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapiesFederica Barbieri, Manuela Albertelli, Federica Grillo, et al.
Endocrine-Related Cancer|September 7, 2017
Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial formsCarole Guerin, Pauline Romanet, David Taieb, et al.
Frontiers in Endocrinology|May 13, 2025
Case Report: Late diagnosis of McCune-Albright with severe kyphoscoliosis, acromegaly and tertiary hyperparathyroidismAnna Bogusławska, Maria Komisarz-Calik, Alicja Hubalewska-Dydejczyk, et al.
Journal of Cancer Research and Therapeutics|October 21, 2009
RET genetic screening in patients with medullary thyroid cancer: the Moroccan experienceAinahi Abdelhakim, Anne Barlier, Mohamed Kebbou, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2013
Targeting dopamine receptors subtype 2 (D2DR) in pheochromocytomas: head-to-head comparison between in vitro and in vivo findingsAlexandru Saveanu, Frederic Sebag, Benjamin Guillet, et al.
World Journal of Surgery|January 9, 2010
Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?Anita Skandarajah, Anne Barlier, Nathalie Morlet-Barlat, et al.
Elife|November 28, 2024
Modeling corticotroph deficiency with pituitary organoids supports the functional role of <i>NFKB2</i> in human pituitary differentiationThi Thom Mac, Teddy Fauquier, Nicolas Jullien, et al.
Expert Review of Endocrinology & Metabolism|February 16, 2019
Congenital pituitary hormone deficiencies: role of LHX3/LHX4 genesFrederic Castinetti, Rachel Reynaud, Alexandru Saveanu, et al.
Annales D'Endocrinologie|December 16, 2017
Unilateral aggressive pheochromocytoma revealed by a massive intraperitoneal hemorrhage five years after an initial presentation suggesting an adrenal hematomaOlivier Gilly, Françoise Brucker-Davis, Jean-Louis Bernard, et al.
Pageof 17